Moderna Inc (MRNA)

Debt-to-equity ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 13,854,000 13,455,000 16,949,000 18,863,000 19,123,000 17,992,000 17,985,000 17,075,000 14,145,000 10,124,000 6,704,000 3,838,000 2,561,000 2,760,000 2,947,000 1,641,000 1,175,000 1,248,190 1,334,960 1,442,320
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $13,854,000K
= 0.00

The debt-to-equity ratio of Moderna Inc has been relatively stable over the past eight quarters, ranging from 0.04 to 0.06. This ratio indicates that the company has a low level of debt in comparison to its equity, reflecting a conservative approach to financial leverage. The slight fluctuations in the ratio suggest that the company is effectively managing its debt levels to support its operations and growth initiatives. Overall, Moderna Inc's debt-to-equity ratio demonstrates a healthy balance between debt and equity financing, which could provide stability and security to its stakeholders.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Debt to Equity (Quarterly Data)